These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32353805)

  • 1. Sugammadex versus neostigmine for reversal of rocuronium-induced neuromuscular blockade: A randomized, double-blinded study of thoracic surgical patients evaluating hypoxic episodes in the early postoperative period.
    Moon TS; Reznik S; Pak T; Jan K; Pruszynski J; Kim A; Smith KM; Lu R; Chen J; Gasanova I; Fox PE; Ogunnaike B
    J Clin Anesth; 2020 Apr; 64():109804. PubMed ID: 32353805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade in Patients With Severe Renal Impairment: A Randomized, Double-Blinded Study.
    Oh MW; Mohapatra SG; Pak T; Hermawan A; Chen CA; Thota B; Chen J; Siu E; Park J; Moon TS
    Anesth Analg; 2024 May; 138(5):1043-1051. PubMed ID: 38190344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
    Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
    Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of recovery after sugammadex or neostigmine reversal of rocuronium in geriatric patients undergoing spine surgery: a randomized controlled trial.
    Mraovic B; Timko NJ; Choma TJ
    Croat Med J; 2021 Dec; 62(6):606-613. PubMed ID: 34981693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects.
    Wu X; Oerding H; Liu J; Vanacker B; Yao S; Dahl V; Xiong L; Claudius C; Yue Y; Huang Y; Abels E; Rietbergen H; Woo T
    BMC Anesthesiol; 2014; 14():53. PubMed ID: 25187755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
    J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of reversal of neuromuscular blockade with sugammadex or neostigmine on postoperative quality of recovery following a single bolus dose of rocuronium: A prospective, randomized, double-blinded, controlled study.
    Kim NY; Koh JC; Lee KY; Kim SS; Hong JH; Nam HJ; Bai SJ
    J Clin Anesth; 2019 Nov; 57():97-102. PubMed ID: 30939422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sugammadex versus neostigmine for neuromuscular blockade reversal in outpatient surgeries: A randomized controlled trial to evaluate efficacy and associated healthcare cost in an academic center.
    Fiorda Diaz J; Echeverria-Villalobos M; Esparza Gutierrez A; Dada O; Stoicea N; Ackermann W; Abdel-Rasoul M; Heard J; Uribe A; Bergese SD
    Front Med (Lausanne); 2022; 9():1072711. PubMed ID: 36569123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade.
    Goodner JA; Likar EJ; Hoff AL; Quedado JM; Kohli A; Ellison P
    Cureus; 2021 Jun; 13(6):e15413. PubMed ID: 34249560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
    Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
    Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study.
    Voss T; Wang A; DeAngelis M; Speek M; Saldien V; Hammer GB; Wrishko R; Herring WJ
    Paediatr Anaesth; 2022 Mar; 32(3):436-445. PubMed ID: 34878707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUGAMMADEX versus neostigmine after ROCURONIUM continuous infusion in patients undergoing liver transplantation.
    Deana C; Barbariol F; D'Incà S; Pompei L; Rocca GD
    BMC Anesthesiol; 2020 Mar; 20(1):70. PubMed ID: 32213163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial.
    Horrow JC; Li W; Blobner M; Lombard J; Speek M; DeAngelis M; Herring WJ
    BMC Anesthesiol; 2021 Feb; 21(1):62. PubMed ID: 33639839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients.
    Woo T; Kim KS; Shim YH; Kim MK; Yoon SM; Lim YJ; Yang HS; Phiri P; Chon JY
    Korean J Anesthesiol; 2013 Dec; 65(6):501-7. PubMed ID: 24427455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of Partial Neuromuscular Block and the Ventilatory Response to Hypoxia: A Randomized Controlled Trial in Healthy Volunteers.
    Broens SJL; Boon M; Martini CH; Niesters M; van Velzen M; Aarts LPHJ; Dahan A
    Anesthesiology; 2019 Sep; 131(3):467-476. PubMed ID: 31045894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.